Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

CML State of the Art 2019: 2nd Generation TKIs Improve Molecular Outcomes and Are Generally Safe, Generic Imatinib Works Well, TFR is a Reality

November 18, 2019

0 Comments
Login to view comments. Click here to Login